Key result
Cerebral embolic protection devices reduce cerebral infarct volume during transcatheter aortic valve replacement, but their impact on clinically evident ischemic strokes remains unclear.
Why the study?
Do cerebral embolic protection devices reduce the risk of peri-procedural ischemic stroke in patients undergoing transcatheter aortic valve replacement?
Do cerebral embolic protection devices reduce the risk of peri-procedural ischemic stroke in patients undergoing transcatheter aortic valve replacement?
Answers are grounded in this paper and cite their sources.
This systematic review evaluates the current evidence for using cerebral embolic protection devices to minimize peri-procedural stroke risk during TAVR.
Transcatheter aortic valve replacement is the therapy of choice for patients with severe aortic stenosis who have prohibitive or high surgical risk. However, the benefit of TAVR is attenuated by the occurrence of major disabling stroke which is associated with increased mortality and early-reduced quality of life. Despite advances in TAVR technology, stroke remains a serious complication that is associated with significant negative outcomes. The majority of these occur in the acute phase following TAVR where cerebral embolic events are frequent. Cerebral embolic protection devices (CEPD) have been developed to minimize the risk of peri-procedural ischemic stroke during TAVR. CEPD have the potential to reduce intraprocedural burden of new silent ischemic injury. In this review we outline the etiology and incidence of stroke in TAVR population, and systematically review current evidence for cerebral embolic protection devices.
No takes yet. Share an insight, caveat, or question.
Demir et al. (2018) conducted a review in Severe aortic stenosis undergoing Transcatheter Aortic Valve Replacement (TAVR). Cerebral Embolic Protection Devices (CEPD) vs. Unprotected TAVR was evaluated. Cerebral embolic protection devices reduce cerebral infarct volume during transcatheter aortic valve replacement, but their impact on clinically evident ischemic strokes remains unclear.
Synapse has enriched 10 related papers. Consider them for comparative context: